Cancer is defined as a disease where abnormal cells proliferate in an uncontrolled fashion. It is a disease that can develop within almost every part of the human body and affects thousands of Australians every year.
Cancers are named based on where they originate in the body, even if that cancer then spreads elsewhere. The most common cancer diagnosed in men is prostate cancer (originating in the prostate), and in women, breast cancer. Colorectal cancer, melanoma, lung cancer and lymphoma are the next most common cancers in both men and women*.
At the Institute our cancer researchers tackle the mysteries of cancer from a number of different perspectives. Some carry out research into specific cancers, such as cancer of the lung, bowel, endometrium, brain, bladder and stomach. Others investigate the role that innate immunity, specific proteins and cancer stem cells play in the onset and development of the disease. Importantly, our Phase I Clinical Trials Program provides researchers with the potential to translate laboratory findings into new cancer therapies for patients.
MIMR is a partner in the Monash Comprehensive Cancer Consortium (MCCC); a partnership between MIMR, Monash University, Southern Health, Prince Henry’s Institute, Cabrini Health, Alfred Health and Peninsula Health. MCCC members aim to promote greater collaboration and translational research programs involving cancer researchers and clinicians from across south-east Melbourne and regional campuses.
For more information on MIMR cancer research visit:
*Source: Cancer in Australia: an overview, 2008 [Australian Institute of Health and Welfare]